U.S. has 3 million stroke patients who suffer limited lower limb mobility.

Shire's $32.5 billion acquisition of Baxalta will be announced as early as Monday.

Pfizer Inc. and Allergan Plc may announce an agreement as early as Monday to combine into a single new firm.

The combined firm would have more than 1,200 hospitals and about 20,000 doctors.

Sprout’s drug Addyi won approval from the FDA on Tuesday to treat a lack of sexual desire in women.

IPC specializes in providing medical staff for patients who are hospitalized or need additional follow-up care.

St. Jude is aiming to expand its portfolio of devices for the treatment of heart failure.

Bayer is shedding peripheral units as he focuses on more lucrative life-sciences operations.

The $1.2bn acquisition will boost Cardinal Health's generic drug distribution.

Opko will gain access to genetic data and sequencing technologies to aid medical discovery.